## **Trustees’ Annual Report for the period** ## **From: 01 Dec 23** ## **Period end date: 30 Nov 2024** ## **Charity name: British Society of Pharmacy Sleep Services (BSPSS)** **Charity registration number** : 1198553 ## **Objectives and Activities** ||SORP reference|| |---|---|---| |Summary of the purposes of
the charity as set out in its
governing document|Para 1.17|We provide essental informaton to
pharmacists to improve patent access to
evidence-based sleep informaton at the
earliest possible stage and raise awareness of
symptoms and the treatments available for
those sufering from sleep disorders. We
engage in research that accelerates access to
evidence-based help for sleep disorders.
We do this to advance health and save lives of
those directly and indirectly impacted by sleep
disorders.| |Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|We contnued with our partner the Chemist +
Druggist (no fee transfer either way) to make
our content free CPD and widely available.
We have created independent and evidence-
based video educaton content for Community
Pharmacy about suspected sleep disorders.
We remimbursed a trustee for reasonable
travel expenses to record video content £80| |Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|The trustees consider that the charity’s
actvites provided public beneft through the
advancement of evidence-based sleep services
in Community Pharmacy, and research to
develop the protocols and tools to enable
wider access.
Suspected sleep disorder suferers in the
Cambridgeshire area have benefted directly
and in the process we are developing the
model of care for a larger roll out.
Patents that would not typically be assessed
for sleep disorders have been identfed (e.g.
post-menopausal women)and have now| received treatment enhancing both their quality of life and life expectancy. ## **Additional information (optional)** You may choose to include further statements where relevant about: ||SORP reference|| |---|---|---| |Policy on grant making|Para 1.38|We are not a grant making charity.| |Policy on social investment
including program related
investment|Para 1.38|We have neither the funds for such an
investment or intenton to create a relevant
policy.| |Contribution made by
volunteers|Para 1.38|Our very existence and day-to-day actvites are
entrely reliant on the goodwill and eforts of
the trustees and our volunteer CEO.| |Other||We have been fortunate to have volunteer
design and marketng expertse freely given.| |**Achievements and Performance**||| ||SORP reference|| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|We atended the Pharmacy Show and were
overwhelmed with interest. This made our
sponsors very happy.
We were fortunate to partner with Newcastle
University, school of pharmacy to
independently write up our feasibility study.
BSPSS was a fnalist in the Chemist and
Druggist awards in one category.
We delivered 4 sleep workshops at King’s
College London for MPharm year 4 student
pharmacists. This was well received and we
have been invited back for the next academic
year.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |
Achievements against
objectives set|
Para 1.41|
We exceeded expectatons in so much that our
contnued partnership with the Chemist +
Druggist signifcantly raised our profle.
Partcipated in social media, podcasts and blogs
that raised awareness and our profle.| |---|---|---| |Performance of fundraising
activities against objectives
set|Para 1.41|On track and some success raising funds.
We found that our current lack of funds
precluded us from raising funds from
pharmaceutcal companies (for fear of undue
infuence).| |Investment performance
against objectives|Para 1.41|We do not currently make fnancial
investments.| |Other||| ## **Financial Review** |**Financial Review**||| |---|---|---| |Review of the charity’s
financial position at the end
of the period|Para 1.21|During the financial year (1stDec 2023 to
30thNov 24) we received £4722 and spent
£5368. We are solvent and optimistic.| |Statement explaining the
policy for holding reserves
stating why they are held|Para 1.22|N/A| |Amount of reserves held|Para 1.22|N/A| |Reasons for holding zero
reserves|Para 1.22|N/A| |Details of fund materially in
deficit|Para 1.24|N/A| |Explanation of any
uncertainties about the
charity continuing as a going
concern|Para 1.23|N/A| ## **Additional information (optional)** ## You may choose to include further statements where relevant about: Commercial donations in the form of unconditional educational grants. The charity’s principal sources of funds (including Para 1.47 any fundraising) Not currently applicable. |Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|| |---|---|---| |A description of the principal
risks facing the charity|Para 1.46|We have limited funds, which restricts our
choices.
While we cannot pay our CEO, this presents us
with tme limitatons.
We antcipate raising funds, paying the CEO,
and eliminatngthis risk.| |Other||| ## **Structure, Governance and Management** |Description of charity’s
trusts:||| |---|---|---| |Type of governing document
(trust deed, royal charter)|Para 1.25|CIO by Foundaton.| |How is the charity
constituted?
(e.g unincorporated
association, CIO)|Para 1.25|Charitable Incorporated Organisaton by
foundaton.| |Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|Trustees are selected by majority board
decision.
The trustees check that the candidates have
not been disqualifed from actng as trustees,
and candidates are asked to confrm in writng
that this is the case.
Candidates are asked to consider and declare
any existng or potental conficts of interest.
If the charity works with children or adults at
risk, the trustees seek any appropriate checks
from the Disclosure and Barring Service.
In the light of the checks and declaratons, the
trustees decide to go ahead and formalise the
appointment of new trustees.| |**Additional information (optional)**
You may choose to include further statements where relevant about:||| |Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|Through ordinary resoluton of the charity.
- The trustees may appoint a person who is
willing to act as a Trustee.| |The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|CIO by foundaton.
The charity is not part of a wider network.| |Relationship with any
related parties|Para 1.51|N/A| |Other||| ## **Reference and Administrative details** |Charity name|The British Society of Pharmacy Sleep Services| |---|---| |Other name the charity uses|BSPSS| |Registered charitynumber|1198553| |Charity’s principal address|4 Waterford Lane, Cherry Willingham, Lincoln, LN3 4AL| ||| ## **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20||**Trustee name**||**Office (if any)**|**Dates acted if not for whole**
**year**||**Name of person (or body) entitled**
**to appoint trustee (ifany)**| |---|---|---|---|---|---|---|---| |||GARETH EVANS||President|||Foundingtrustees| |||LIZZIE HILL||Education|||Foundingtrustees| |||~~JOANNA KIPPAX~~||~~Education~~|Retired 13 Oct 2023||~~Founding trustees~~| |||ROD TUCKER||Research|||Foundingtrustees| |||BREEGE LEDDY||Education|||Foundingtrustees| |||EDWARD GRANDI||Treasurer|||Foundingtrustees| |||ADRIAN WILLIAMS||Education|Appointed August 2023||Board of Trustees| |||LOUISE BERGER||Education|Appointed 16 Oct 2023||Board of Trustees| |||RAJ NUTAN||Commercial
strategy|Appointed 23 May 2024||Board of Trustees| ||||||||| ||||||||| ||||||||| ||||||||| ||||||||| ||||||||| ||||||||| ||||||||| ||||||||| ||||||||| ||||||||| ## – Corporate trustees names of the directors at the date the report was approved |
**Director name**||| |---|---|---| |Adrian Zacher||Volunteer CEO| |||| |||| |||| |||| |||| Name of trustees holding title to property belonging to the charity **Trustee name Dates acted if not for whole year** ## **Funds held as custodian trustees on behalf of others** Description of the assets Not applicable held in this capacity Name and objects of the Not applicable charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for Not applicable safe custody and segregation of such assets from the charity’s own assets ## **Additional information (optional)** ## **Names and addresses of advisers (Optional information)** **Type of Name Address adviser** ## **Name of chief executive or names of senior staff members (Optional information)** Adrian Zacher ## **Exemptions from disclosure** Reason for non-disclosure of key personnel details Not applicable ## **Other optional information** Not applicable ## **Declarations** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s)** **Full name(s)** **Position (eg Secretary, Chair, etc)** **Date** **British Society of Pharmacy Sleep Services (BSPSS) No (if any) Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** 12/1/2024 11/30/2025 ## **Section A Receipts and payments** |**to the nearest £**
**A1 Receipts**
IDORSIA PHARMACEUT
SOMNOMED UK LTD
SNORER.COM LTD
PAYPAL - DONATION
ITAMAR MEDICAL UK
SEFAM MEDICAL LTD
**-**
**-**
**-**
**-**
**-**
**_Sub total_ -**
**_Total receipts_ -**
**A3 Payments**
Events & exhibition
Software / subscriptions
**-**
Reimbursement of Trustee Travel
**-**
Regulator
**-**
Insurance
**-**
Travel
**-**
**-**
**-**
**_Sub total_ -**
**-**
**-**
**_Sub total_ -**
**_Total payments_ -**
**_Net of receipts/(payments)_ -**
**A5 Transfers between funds**
**-**
**A6 Cash funds last year end**
**-**
**_Cash funds this year end_ -**
**Unrestricted**
**funds**
**_Sub total_**_(Gross income for AR)_
**A2 Asset and investment sales,**
**(see table).**
**A4 Asset and investment**
**purchases, (see table)**|**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Restricted**
**funds**|**to the nearest £**
1173
1000
500
48
1000
1000
**-**
**-**
**4,721**
**-**
**-**
**-**
**4,721**
4397
**247**
**80**
**85**
**280**
**279**
**-**
**-**
**5,368**
**-**
**-**
**-**
**5,368**
**- 647**
**-**
**-**
**- 647**
**Endowment**
**funds**|**Total funds**
**to the nearest £**
**1,173**
**1,000**
**500**
**48**
**1,000**
**1,000**
**-**
**-**
**4,721**
**-**
**-**
**-**
**4,721**
**4,397**
**247**
**80**
**85**
**280**
**279**
**-**
**-**
**5,368**
**-**
**-**
**-**
**5,368**
**- 647**
**-**
**-**
**- 647**|**Last year**
**to the nearest £**| |---|---|---|---|---| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||| |||||| |||||**-**| |||||**-**| |||||| |||||**-**| |||||| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||**-**| |||||| |||||| |||||| |||||**-**| |||||| |||||**-**| |||||| ||**-**|**- 647**|**- 647**|**-**| ||**-**|**-**|**-**|**-**| ||**-**|**-**|**-**|**-**| ||**-**|**- 647**|**- 647**|**-**| ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
**B1 Cash funds**
**B2 Other monetary assets**
**B3 Investment assets**
**B5 Liabilities**
**B4 Assets retained for the**
**charity’s own use**
Signed by one or two trustees on
behalf of all the trustees|**Details**
**Details**
**Details**
**Details**
**Details**
Signature
**_Total cash funds_**
(agree balances with receipts and payments
account(s))|**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
OK
OK
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
Print Name
**Unrestricted**
**funds**
**Restricted**
**funds**
**Unrestricted**
**funds**
**Restricted**
**funds**
**Fund to which**
**asset belongs**
**Fund to which**
**asset belongs**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**|**to nearest £**
**Endowment**
**funds**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||Agreement Error| ||||**to nearest £**
**Endowment**
**funds**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| ||||| |||||